Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Part of paid clinical trials in San Francisco, California.

Sponsor
Ascidian Therapeutics, Inc
Study ID
NCT06445322
Status
Recruiting
Apply to this trial

Conditions

  • Cone Rod Dystrophy
  • Juvenile Macular Degeneration
  • Stargardt Disease
  • Stargardt Disease 1

Eligibility Criteria

Sex
ALL
Age
5 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Prescreening Assessments — DIAGNOSTIC_TEST
    Various genetic and visual assessments.

Study Details

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

Key Dates

Start date
Jun 20, 2024
Status verified
May 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2030

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Prescreening Group
    The prescreening study consists of genetic and visual assessments and will require at least 1 onsite visit. All clinical assessments performed are for the purpose of determining research eligibility for ACDN-01 clinical trials.

Primary Outcome Measure

Confirm mutations in the ABCA4 gene [ Time Frame: 12 months ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
University of San FranciscoSan FranciscoCalifornia94158-
Vitreo Retinal AssociatesGainesvilleFlorida32607-
Wilmer Eye Institute at John HopkinsBaltimoreMaryland21218-
Massachusetts Eye and EarBostonMassachusetts02114-
University of Michigan Kellogg Eye CenterAnn ArborMichigan48105-
Cincinnati Eye InstituteCincinnatiOhio45245-
Retina Foundation of TexasDallasTexas75382-
Retina Consultants of TexasHoustonTexas77401-

Find similar trials in San Francisco, CA

By research site
University of San Francisco· San Francisco, CAVitreo Retinal Associates· Gainesville, FLWilmer Eye Institute at John Hopkins· Baltimore, MDMassachusetts Eye and Ear· Boston, MAUniversity of Michigan Kellogg Eye Center· Ann Arbor, MICincinnati Eye Institute· Cincinnati, OH

Related Studies